Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorouracil With or Without Mitomycin in Peritoneal Cancer
NCT00006112Phase 2Unknown
- Sponsor
- Gustave Roussy
- Start
- Jan 1996
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of mitomycin c in primary peritoneal cancer (PPC) (2 arms), sponsored by Gustave Roussy. Primary endpoint: Overall Survival at 2 years. Status: unknown.
02
Drugs
mitomycin c
03
Conditions
primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00006112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006112.